2-STEP BINDING MECHANISM FOR HIV PROTEASE INHIBITORS

被引:54
作者
FURFINE, ES
DSOUZA, E
INGOLD, KJ
LEBAN, JJ
SPECTOR, T
PORTER, DJT
机构
[1] WELLCOME RES LABS, DIV ORGAN CHEM, RES TRIANGLE PK, NC 27709 USA
[2] WELLCOME RES LABS, DIV MOLEC SCI, BECKENHAM BR3 3BS, KENT, ENGLAND
关键词
D O I
10.1021/bi00149a020
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Rate constants for binding of five inhibitors of human immunodeficiency virus (HIV) protease were determined by stopped-flow spectrofluorometry. The two isomers of quinoline-2-carbonyl-Asn-Phe-psi-[CH (OH)CH2N]Pro-O-t-Bu (R diastereomer = 1R; S diastereomer = 1S) quenched the protein fluorescence of HIV protease and thus provided a spectrofluorometric method to determine their binding rate constants. The dissociation rate constants for acetyl-Thr-Ile-Leu-psi(CH2NH)Leu-Gln-Arg-NH2 (2), (carbobenzyloxy)Phe-psi[CH (OH)CH2N]Pro-O-t-Bu (3), and pepstatin were determined by trapping free enzyme with 1R as 2, 3, and pepstatin dissociated from the respective enzyme-inhibitor complex. Association rate constants of 1R, 2, and pepstatin were calculated from the time-dependent inhibition of protease-catalyzed hydrolysis of the fluorescent substrate (2-aminobenzoyl)-Thr-Ile-Nle-Phe(NO2)-Gln-Arg-NH2 (4). The kinetic data for binding of 1S to the protease fit a two-step mechanism. K(d) values for these inhibitors were calculated from the rate constants for binding and were similar to the respective steady-state K(i) values.
引用
收藏
页码:7886 / 7891
页数:6
相关论文
共 33 条
  • [1] BERDE CB, 1979, J BIOL CHEM, V254, P391
  • [2] Bevington P.R., 1969, DATA REDUCTION ERROR
  • [3] Cleland W W, 1979, Methods Enzymol, V63, P103
  • [4] HUMAN IMMUNODEFICIENCY VIRUS PROTEASE EXPRESSED IN ESCHERICHIA-COLI EXHIBITS AUTOPROCESSING AND SPECIFIC MATURATION OF THE GAG PRECURSOR
    DEBOUCK, C
    GORNIAK, JG
    STRICKLER, JE
    MEEK, TD
    METCALF, BW
    ROSENBERG, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (24) : 8903 - 8906
  • [5] DESIGN, ACTIVITY, AND 2.8 A CRYSTAL-STRUCTURE OF A C2 SYMMETRICAL INHIBITOR COMPLEXED TO HIV-1 PROTEASE
    ERICKSON, J
    NEIDHART, DJ
    VANDRIE, J
    KEMPF, DJ
    WANG, XC
    NORBECK, DW
    PLATTNER, JJ
    RITTENHOUSE, JW
    TURON, M
    WIDEBURG, N
    KOHLBRENNER, WE
    SIMMER, R
    HELFRICH, R
    PAUL, DA
    KNIGGE, M
    [J]. SCIENCE, 1990, 249 (4968) : 527 - 533
  • [6] DETERMINATION OF THE RELATIVE BINDING FREE-ENERGIES OF PEPTIDE INHIBITORS TO THE HIV-1 PROTEASE
    FERGUSON, DM
    RADMER, RJ
    KOLLMAN, PA
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (08) : 2654 - 2659
  • [7] Fersht A., 1985, ENZYME STRUCTURE MEC, P121
  • [8] FITZGERALD PMD, 1990, J BIOL CHEM, V265, P14209
  • [9] ROLE OF CAPSID PRECURSOR PROCESSING AND MYRISTOYLATION IN MORPHOGENESIS AND INFECTIVITY OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1
    GOTTLINGER, HG
    SODROSKI, JG
    HASELTINE, WA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (15) : 5781 - 5785
  • [10] COMPARISON OF INHIBITOR BINDING IN HIV-1 PROTEASE AND IN NONVIRAL ASPARTIC PROTEASES - THE ROLE OF THE FLAP
    GUSTCHINA, A
    WEBER, IT
    [J]. FEBS LETTERS, 1990, 269 (01) : 269 - 272